<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114384">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02007967</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00070087</org_study_id>
    <nct_id>NCT02007967</nct_id>
  </id_info>
  <brief_title>Non-Contrast Magnetic Resonance Angiography Assessment of Patients Referred for Transcatheter Aortic Valve Implantation</brief_title>
  <official_title>Can Non-Contrast Magnetic Resonance Angiography Accurately Define Arterial Access and Aortic Root Anatomy in Patients Referred for Transcatheter Aortic Valve Implantation?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of this proposal is to examine the feasibility and accuracy of
      non-contrast magnetic resonance angiography (MRA) to comprehensively evaluate individuals
      referred for transcatheter aortic valve implantation (TAVI).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Minimal luminal size for aorta and ileofemoral arteries</measure>
    <time_frame>3 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Compare luminal diameter for each segment of the ileofemoral arteries and aorta between MRI and CT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Graded image quality</measure>
    <time_frame>3 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Compare graded image quality for ileofemoral arteries, aorta, and aortic annulus between MRI and CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Annular size</measure>
    <time_frame>3 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Compare annular diameter, area, and perimeter between MRI and CT</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will include patients undergoing clinically indicated computed tomography
        angiography for evaluation for possible transcatheter aortic valve implantation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults with severe aortic stenosis referred for possible transcatheter aortic valve
             implantation with clinically indicated computed tomography imaging

        Exclusion Criteria:

          -  Inability or unwillingness to consent

          -  Inability to complete magnetic resonance imaging (MRI) study

          -  Contraindication to MRI

          -  Participation in another research study

          -  Non-diagnostic computed tomography scan
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Troy M LaBounty, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Troy M LaBounty, M.D.</last_name>
    <phone>734-764-7440</phone>
    <email>labt@med.umich.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Michigan Cardiovascular Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 6, 2013</lastchanged_date>
  <firstreceived_date>November 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Troy LaBounty</investigator_full_name>
    <investigator_title>Assistant Professor, Internal Medicine</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
